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Background—The relationship of the full range of alcohol consumption with risk of incident atrial fibrillation has been
inconsistent in previous, mainly case-control studies.
Methods and Results—In a prospective cohort study, we studied the association between self-reported alcohol use and
incident atrial fibrillation among 16 415 women and men enrolled in the Copenhagen City Heart Study. We ascertained
use of beer, wine, and spirits individually at up to 3 study visits with a structured questionnaire. We identified cases of
atrial fibrillation by routine study ECGs and a validated nationwide registry of all hospitalizations. A total of 1071 cases
occurred during follow-up. Among both women and men, alcohol consumption throughout the moderate range was not
associated with risk of atrial fibrillation. However, consumption of 35 or more drinks per week among men was
associated with a hazard ratio of 1.45 (95% CI 1.02 to 2.04); few women consumed this amount of alcohol.
Approximately 5% of cases of atrial fibrillation among men were attributable to heavy alcohol use. Further adjustment
for blood pressure and incident coronary heart disease and congestive heart failure did not attenuate the association
(hazard ratio 1.63; 95% CI 1.15 to 2.31).
Conclusions—Heavy alcohol consumption is associated with a higher risk of atrial fibrillation, at least among men. This
relationship does not appear to be related to the adverse effects of heavy drinking on coronary heart disease or blood
pressure. (Circulation. 2005;112:1736-1742.)
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Substantial evidence indicates that moderate alcohol con-sumption is associated with a lower risk of cardiovascular
disease than abstention or heavy drinking.1,2 Cohort studies
also suggest that moderate alcohol use is inversely associated
with risk of congestive heart failure.3,4 However, although
anecdotal evidence implicates episodic heavy drinking as a
trigger of atrial fibrillation (AF),5 the relationship of the full
range of alcohol use with risk of incident AF is less certain.
At least 4 case-control studies have found relatively similar
odds of AF among abstainers and moderate drinkers but
significantly higher odds of AF among heavier drinkers.6–9 A
recent cohort study found a higher risk of AF even among
men who consumed 2 drinks per day.10 However, 2
prospective cohort studies have not confirmed this find-
ing,11,12 and Psaty and colleagues12 found that alcohol use
was inversely associated with risk of AF in the Cardiovascu-
lar Health Study. Moreover, experimental studies suggest that
alcohol administration decreases susceptibility to and dura-
tion of AF in canine models.13,14 Thus, substantial contro-
versy remains about the relation of alcohol use and risk of
AF.
To address the prospective association of alcohol use and
risk of AF more fully, we studied more than 16 000 partici-
pants of the Copenhagen City Heart Study (CCHS), a
population-based cohort study of residents of Copenhagen,
Denmark. As part of the study, participants have received
routine resting ECGs at 3 examinations, and a national
register records diagnoses from all hospitalizations, which
provides reliable and valid assessments of incident AF.
Methods
Study Population
The CCHS began in 1976 with an original population sample of
19 698 persons randomly drawn from the Copenhagen Population
Register, of whom 14 223 attended an initial examination. After the
first examination in 1976 to 1978, this sample (including individuals
who did not attend the first examination) was reinvited to participate
in 2 more examinations in 1981 to 1983 and in 1991 to 1994. At the
second examination in 1981 to 1983, an additional sample of 500
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participants (aged 20 to 24 years) was invited, and at the third
examination in 1991 to 1994, a final 3000 subjects (aged 20 to 49
years) were invited. The number of new participants was 14 223 at
the first visit, 1563 at the second, and 2360 at the third, for a total of
18 146 individuals. At each of the 3 examinations, participants
completed a questionnaire concerning their medical history, socio-
economic status, exercise, smoking, and drinking habits. We ex-
cluded participants with prevalent AF on their baseline ECG
(n118); those with self-reported coronary heart disease, stroke, use
of cardiac medication, or use of antihypertensives at baseline
(n1431); and those with missing information on alcohol use
(n180), which left us with 16 415 participants eligible for analysis.
The CCHS was approved by the Ethics Committee of Copenhagen
and Frederiksberg Municipality, Denmark. New and returning par-
ticipants gave informed consent verbally at the first 2 examinations
(ie, up to 1983) and in writing at each subsequent examination.
Assessment of Alcohol Consumption
Participants reported their alcohol use in standardized interviews.
They individually reported their intake of beer (in bottles), wine (in
glasses), and spirits (in units), with response categories of “never/
hardly ever,” “monthly,” “weekly,” or “daily” and number of drinks
per day among daily drinkers. As previously described,15,16 less-
than-daily intake was estimated from these categories by regression
and added to daily intake (of those beverages consumed daily) as
needed. In a validation analysis, the age-adjusted correlation coeffi-
cients between self-reported alcohol intake and measured levels of
HDL cholesterol were 0.20 among men and 0.22 among women
(P0.001 for both), similar to findings from other representative
cohorts.17,18
We classified participants according to their usual weekly intake
of alcohol as in previous studies19: 1 serving, 1 to 6 servings, 7 to
13 servings, 14 to 20 servings, 21 to 27 servings, 28 to 34 servings,
and 35 servings. Because of the more limited range of intake
among women, their highest category of alcohol intake was 21
servings per week.
Because intake was queried separately for each alcoholic bever-
age, we could not determine overall drinking frequency in the entire
cohort with certainty. Using the response categories noted, we
estimated drinking frequency among the subset of participants who
predominately consumed a single beverage type (90% of their
overall alcohol use).
Determination of AF
Participants underwent a resting 12-lead ECG at each study exami-
nation. Each ECG was coded according to the Minnesota coding
system by 2 independent coders; in cases of dispute, a third coder
settled the disagreement. A physician then reviewed and confirmed
all ECGs classified as AF. In a randomly chosen sample representing
10% (817/8170) of patients aged 65 years with ECGs initially
coded without AF, only 2 ECGs (0.2%) were recoded as AF on
review.20
In addition, the Danish National Hospital Discharge Register
records discharge diagnoses from all Danish hospital admissions. We
identified first hospitalizations with a diagnosis of AF using Inter-
national Classification of Diseases, 8th Revision (ICD-8) codes
427.93 and 427.94 through 1993 and International Classification of
Diseases, 10th Revision (ICD-10) code I48.9 from 1994 forward.
In a previous validation of this registry, review of a subset of 116
medical records by a cardiologist confirmed the diagnosis in 112
cases.10 We further assessed the validity of our determinations of AF
by review of a random sample of 25 medical records coded with AF
and 25 medical records coded with coronary heart disease (but not
AF) by a single cardiologist (JF). Three records coded with AF had
no evidence of AF during hospitalization (specificity 88%); 3 records
coded without AF had ECG evidence of AF (sensitivity 88%).
We also examined the validity of AF diagnoses in 2 additional
ways. First, we found an incidence rate of AF after the third
examination for adults 65 years and older of 11.6 cases per 1000
person-years; the comparable incidence rate in an older population in
the United States during a similar time period was 19.2/1000.12
Second, we found that participants with AF diagnosed in this manner
had a multivariable-adjusted hazard ratio of stroke (using published
criteria21) after the diagnosis of AF of 2.62 (95% CI 2.14 to 3.21)
among men and 4.85 (95% CI 4.02 to 5.87) among women.
Other Covariates
Arterial blood pressure was measured in the left arm with the patient
in the sitting position after 5 minutes’ rest. Study staff measured
height and weight with subjects dressed in loose-fitting clothing
without shoes. We classified participants as having diabetes if they
reported a physician-made diagnosis or if they had a nonfasting
glucose of 11.1 mmol/L (200 mg/dL) at any examination.
Statistical Analysis
We describe baseline characteristics of CCHS participants with
median values for continuous variables and proportions for categor-
ical variables. We tested for homogeneity in baseline characteristics
with Kruskal-Wallis tests for continuous variables and 2 tests for
categorical variables.
Participants accrued person-time from study entry until their first
hospitalization with AF, the first examination at which AF was
noted, death, or January 1, 2001. Because we did not have data on
hospitalizations before the first study examination (with which to
exclude participants in sinus rhythm with a history of AF), we
excluded the 2 participants in the original cohort with a diagnosis of
AF within 1 year of study entry. In a sensitivity analysis, we set the
censoring date for participants with AF diagnosed at each study
examination to the median censoring date of participants diagnosed
by hospitalization in the preceding time period; this did not change
our results.
In initial multivariable Cox proportional hazards regression anal-
yses, we simultaneously adjusted for age, height, body mass index,
smoking, physical activity, education, income, family history of
cardiovascular disease, cohabitation, FEV1 (forced expiratory vol-
ume in 1 second), and history of diabetes. We assigned indicator
variables to participants with missing information on FEV1 (n828),
income (n493), and body mass index (n451); analyses restricted
to participants without missing information for covariates yielded
very similar results that are not shown here. Age was used as the time
axis in Cox models to ensure comparison of individuals at the same
age and hence maximize adjustment for age.
To evaluate possible mediators, we performed analyses that
additionally adjusted for systolic blood pressure and treated hyper-
tension, incident congestive heart failure, and incident coronary heart
disease. Heavy alcohol intake has been identified as a risk factor for
each of these variables,22 and all have been associated with risk of
AF,12 which implies that they could explain at least part of an
association between alcohol intake and risk of AF. For the latter 2
variables, we used time-varying covariates set to the date of first
hospitalization for each diagnosis.
We performed primary analyses using updated measures of
alcohol consumption and other covariates, in which we prospectively
assessed the risk of AF in between-examination increments, based on
determinations of alcohol consumption and other covariates derived
from the preceding questionnaire. We assessed the risk associated
with individual beverage types in similar fashion. In beverage-
specific analyses, we examined the association of individual catego-
ries of intake of a given beverage relative to abstention from that
beverage while simultaneously adjusting for the standard covariates
that we incorporated into other models and for intake of each of the
other 2 beverage types.23 For tests of linear trend, we treated the
median value within categories of alcohol intake as a continuous
variable. To explore the dose-response relationship further, we also
performed regression analyses using linear splines24 with knots at
increments of 3 drinks/wk. We estimated the population-attributable
risk related to heavy alcohol intake using standard methods.25
Results
Baseline Characteristics
Table 1 shows the characteristics of participants categorized
at baseline according to usual alcohol consumption. Individ-
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uals in the lowest drinking category tended to be older and to
have lower income levels, whereas those in the higher
drinking categories were more likely to smoke. Women
consumed wine in the greatest amount, whereas men chiefly
consumed beer.
Average Alcohol Consumption and Risk of AF
We documented 1071 cases of incident AF. Of these 1071, 68
were diagnosed by a study ECG, 891 from hospitalization
records, and 112 from both sources. In both age- and
multivariable-adjusted analyses, the risk of AF was very
TABLE 1. Characteristics of 16 415 CCHS Participants Free of Clinical Cardiovascular Disease According to Usual
Alcohol Consumption
Weekly No. of Drinks
1 1 to 6 7 to 13 14 to 20
21 (Women)
21 to 27 (Men) 28 to 34 35 P
Women n2631 n3969 n1461 n451 n315      
Weekly intake (in drinks) of:
Beer 0 0.9 3.7 4.7 7.0       0.001
Wine 0 1.2 4.8 5.7 14.0       0.001
Liquor 0 0 1.2 1.3 4.6       0.001
Age, y* 56 (33, 73) 50 (25, 68) 48 (26, 69) 49 (31, 69) 50 (33, 68)       0.001
Education 8 y, % 61 37 26 30 29       0.001
Cohabitating, % 63 71 70 73 65       0.001
Ever smokers, % 67 72 77 85 85       0.001
BMI, kg/m2 24.3 23.4 23.0 22.8 23.6       0.001
Height, cm 161 163 164 164 164       0.001
Diabetes, % 3 1 1 0 1       0.001
Exercise intensity, %
None 26 14 13 20 23       0.001
Low 54 60 57 54 49       0.001
Moderate 19 25 28 25 26       0.001
High 1 1 2 2 2       0.26
FEV1, mean % predicted 80.1 81.8 82.0 81.2 81.0       0.001
Family Hx CVD, % 33 33 35 41 32       0.03
Income in lower tertile, % 44 24 22 22 23       0.001
Men n824 n1703 n1799 n1269 n609 n435 n949
Weekly intake (in drinks) of:
Beer 0.1 2.1 7.0 7.4 16 28 35 0.001
Wine 0 1.7 1.7 3.0 2.1 1.7 1.1 0.001
Liquor 0.1 1.0 1.7 2.0 2.0 2.0 2.0 0.001
Age, y* 54 (31, 75) 51 (25, 71) 50 (25, 70) 50 (26, 70) 52 (28, 70) 51 (33, 68) 50 (33, 68) 0.001
Education 8 y, % 54 40 37 36 41 44 50 0.001
Cohabitating, % 71 77 79 77 77 74 68 0.001
Ever smokers, % 83 81 85 89 92 91 93 0.001
BMI, kg/m2 25.2 24.8 25.0 25.1 25.2 25.9 26.1 0.001
Height, cm 173 175 175 175 175 174 174 0.001
Diabetes, % 5 3 3 3 3 5 4 0.08
Exercise intensity, %
None 25 17 15 14 15 22 26 0.001
Low 44 44 48 49 48 45 44 0.01
Moderate 28 34 33 32 32 29 26 0.001
High 4 5 4 4 4 3 4 0.42
FEV1, mean % predicted 79.1 80.7 80.7 80.0 79.3 78.6 78.4 0.001
Family Hx CVD, % 30 27 30 28 33 27 30 0.09
Income in lower tertile, % 38 25 19 19 17 20 21 0.001
BMI indicates body mass index; Family Hx CVD, family history of cardiovascular disease.
Medians and probability values from Kruskal-Wallis tests are shown for continuous variables, and proportions and probability values from 2 tests are shown for
categorical variables.
*Median (5th percentile, 95th percentile).
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similar between abstainers and those who consumed up to 14
drinks per week (Table 2). Among men, we found a higher
risk among consumers of 35 or more drinks per week. We did
not find a similar risk among women who consumed 21 or
more drinks per week, but very few women consumed 28 or
more drinks per week (with a total of only 4 cases of AF
among such women). Given that 12.5% of men in the CCHS
consumed 35 or more drinks per week, we estimate that5%
of cases of AF among men were attributable to this level of
intake.
In stratified analyses (not shown), we found no evidence of
interaction among participants stratified by sex (P0.96),
median age (for men, 55.8 years, P0.22; for women, 56.8
years, P0.32), or median body mass index (for men, 25.5
kg/m2, P0.68; for women, 24.0 kg/m2, P0.49). In all
cases, higher risk was generally restricted to men who drank
heavily. In exploratory analyses, using linear splines, of the
dose-response relationship among men, there appeared to a
threshold relationship similar to that suggested by analyses of
alcohol intake in categories. The risk of AF increased notably
at a threshold of 35 drinks per week, with a relatively flat
relationship at lower levels of intake.
Potential Mediators of the Alcohol-AF Relation
We assessed a series of potential mediators of the association
of heavy alcohol intake with risk of AF, including blood
pressure, incident coronary heart disease during follow-up,
incident congestive heart failure during follow-up, and all 3.
As expected, all 3 were strongly and independently associated
with risk of AF. However, adjustment for these factors
individually or together had relatively little effect on our
results, consistent with the hypothesis that these factors do
not mediate the relation of alcohol use and AF. For example,
the relative risk of AF among men who consumed 35 or more
drinks per week was 1.45 in the basic model (as noted above)
and 1.63 (95% CI 1.15 to 2.31) with further adjustment for all
3 factors (Table 2).
Because the association of intake of 28 to 34 drinks per
week with risk of AF was stronger after adjustment for
mediators, we conducted a post hoc analysis that grouped all
men who consumed 28 or more drinks per week. In this
analysis, the hazard ratio for drinking 28 or more drinks per
week was 1.29 (95% CI 0.95 to 1.77) with multivariable
adjustment and 1.50 (95% CI 1.10 to 2.06) after the inclusion
of potential mediators. Given the latter hazard ratio, 8% of
cases of AF among men were attributable to intake of 28 or
more drinks per week after adjustment for mediators.
Exploratory Analyses of Beverage Type and
Drinking Frequency
Table 3 shows results from exploratory beverage type anal-
yses. There were no statistically significant associations
identified. It appeared that consumption of 21 or more drinks
per week of both beer and spirits tended to be related to
higher risk of AF than found with abstention from these
beverages among men.
We found no clear evidence that drinking frequency was
related to risk of AF in either women or men (data not
shown). This finding was consistent in analyses adjusted for
age, for all covariates, and for all covariates with additional
adjustment for overall quantity of alcohol use.
Discussion
In this prospective cohort study, alcohol intake of 35 or more
drinks per week was associated with a higher risk of AF, at
least among men. Previous studies of the relation of alcohol
use and risk of AF have not yielded consistent results. In a
case-control study from the UK General Practice Research
Database, Ruigomez and colleagues9 found that physician-
reported alcohol use above 42 U per week was associated
TABLE 2. Hazard Ratios and 95% CIs for Risk of AF According to Usual Alcohol Consumption Among CCHS Participants Free of
Cardiovascular Disease
Weekly No. of Drinks
1 1 to 6 7 to 13 14 to 20
21 (Women)
21 to 27 (Men) 28 to 34 35 P*
Women
Cases 248 148 81 28 18      
Person-years 59 466 63 380 27 249 9450 5970      
Age-adjusted 1.00 0.91 (0.74–1.12) 1.04 (0.81–1.34) 1.03 (0.70–1.52) 1.26 (0.78–2.04)       0.35
Multivariable model† (95% CI) 1.00 0.89 (0.72–1.09) 0.99 (0.76–1.28) 0.96 (0.64–1.43) 1.04 (0.64–1.70)       0.87
With mediators‡ 1.00 0.87 (0.70–1.07) 1.04 (0.80–1.35) 1.03 (0.69–1.53) 1.07 (0.65–1.75)       0.60
Men
Cases 81 123 143 75 37 29 60
Person-years 15 834 29 084 30 794 19 198 9345 7049 12 688
Age-adjusted (95% CI) 1.00 0.98 (0.74–1.30) 1.19 (0.91–1.57) 1.01 (0.74–1.39) 1.05 (0.71–1.55) 1.19 (0.78–1.82) 1.62 (1.16–2.27) 0.005
Multivariable model† (95% CI) 1.00 0.96 (0.73–1.28) 1.16 (0.88–1.53) 0.95 (0.69–1.31) 0.98 (0.66–1.45) 1.06 (0.69–1.64) 1.45 (1.02–2.04) 0.05
With mediators‡ (95% CI) 1.00 1.01 (0.76–1.34) 1.26 (0.95–1.66) 1.02 (0.74–1.41) 1.03 (0.69–1.54) 1.31 (0.85–2.02) 1.63 (1.15–2.31) 0.007
*Probability values derive from tests of trend.
†The multivariable model adjusted for age, smoking, education, cohabitation, family history of cardiovascular disease, diabetes, income, physical activity, BMI, FEV1,
and height.
‡Mediators included use of blood pressure medication, systolic blood pressure, and incident diagnoses of coronary heart disease and congestive heart failure
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with an OR of 2.4, with no evidence for an inverse association
at lower levels of consumption. An innovative case-control
analysis of the Framingham Study that incorporated person-
time contributed to the study found an OR of 1.34 (95% CI
1.01 to 1.78) among consumers of more than 36 g (3 drinks)
of alcohol daily but not at lower levels of intake.6 In a
case-control study from Helsinki, consumption of more than
30 g/d was acutely associated with onset of AF, whereas
lighter consumption was not associated with risk.8 An anal-
ysis of the Diet, Cancer, and Health cohort found 25% to 46%
higher risks of AF associated with average intake of 20 g/d
or more among men but not among women.10 In sharp
contrast to these studies, Psaty and colleagues12 found alcohol
use to be inversely associated with risk of AF in a 3-year
follow-up study of the original Cardiovascular Health Study
cohort. To the best of our knowledge, ours is the first
prospective cohort study to support the findings of earlier
case-control studies that suggested a higher risk restricted to
heavy drinking.
The one previous study that assessed beverage type found
no differences in risk,10 despite some evidence that antioxi-
dants can modify AF risk. Mihm and colleagues26 found that
patients with AF have higher levels of 2 markers of oxidative
stress in right atrial myofibrillar isolates than do patients
without AF undergoing cardiac surgery. The same group
subsequently found that ascorbate, an antioxidant, alleviated
the pacing-induced shortening of the atrial effective refrac-
tory period in dogs and that supplemental ascorbate was
associated with an adjusted OR of 0.34 (95% CI 0.10 to 1.19)
for postoperative AF among patients undergoing CABG
surgery.27 In the present study, only the heaviest level of
overall alcohol intake was associated with higher risk, and no
single beverage was consumed in sufficient amounts to
compare their respective effects at that level of consumption
with confidence. Further studies, and perhaps meta-analyses
of existing studies, are needed to clarify this issue.
Heavier drinkers could sustain a higher risk of AF in a few
related ways. First, chronic heavy alcohol use itself could
affect atrial structure and size as a direct cardiotoxin, an effect
suggested in rat models.28 Second, chronic heavy drinking
could have direct proarrhythmic effects. Third, heavier drink-
ers are likely to have repeated exposure to episodic heavy
TABLE 3. Adjusted Hazard Ratios for Risk of AF According to Updated Consumption of Individual
Alcoholic Beverages
Weekly No. of Drinks
1 1 to 6 7 to 13
14 (Women)
14 to 20 (Men) 21 P
Women
Beer
Cases 272 129 14 8   
Person-years 104 854 50 484 7067 3110   
Hazard ratio (95% CI) 1.00 1.04 (0.83–1.30) 0.65 (0.38–1.12) 1.04 (0.51–2.13)    0.36
Wine
Cases 316 160 30 17   
Person-years 78 983 71 646 9275 5612   
Hazard ratio (95% CI) 1.00 0.95 (0.76–1.19) 1.09 (0.73–1.62) 1.13 (0.68–1.88)    0.70
Spirits
Cases 395 92 29 7   
Person-years 116 140 42 229 5454 1692   
Hazard ratio (95% CI) 1.00 0.85 (0.65–1.09) 1.11 (0.75–1.65) 1.19 (0.55–2.57)    0.58
Men
Beer
Cases 123 212 92 52 69
Person-years 24 274 45 758 24 182 12 454 17 323
Hazard ratio (95% CI) 1.00 1.12 (0.88–1.42) 1.01 (0.76–1.34) 1.06 (0.75–1.48) 1.27 (0.92–1.74) 0.26
Wine
Cases 288 203 37 13 7
Person-years 53 260 58 105 7862 3190 1575
Hazard ratio (95% CI) 1.00 0.85 (0.69–1.05) 0.97 (0.67–1.39) 0.81 (0.45–1.43) 0.99 (0.46–2.13) 0.65
Spirits
Cases 269 220 49 25 14
Person-years 58 027 53 766 7592 2766 1842
Hazard ratio (95% CI) 1.00 1.06 (0.86–1.31) 0.92 (0.67–1.28) 1.19 (0.76–1.87) 1.47 (0.85–2.56) 0.26
Probability values derive from tests of trend. Hazard ratios were adjusted for age, smoking, education, cohabitation, family history
of cardiovascular disease, diabetes, income, physical activity, body mass index, FEV1, height, and intake of the other 2 beverages.
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drinking (ie, binge drinking), which could increase the risk of
triggering a single episode of AF. To support this, porcine
models show that acute alcohol administration increases the
inducibility of AF, but mainly at very high blood alcohol
concentrations.29 Fourth, alcohol consumption could cause
brief and otherwise asymptomatic episodes of AF to become
persistent. A case-crossover study of patients with acute AF
could best assess this distinction30 but would not change the
importance of avoiding heavier drinking.
Specific limitations of the present study warrant discus-
sion. As in any observational study, our results could be
influenced by differences between participants in factors
other than alcohol consumption for which we did not control.
For example, we did not have data on dietary factors other
than ethanol, although little is known about how such factors
affect risk of AF; this limitation may particularly affect
beverage type analyses.31 To have influenced our primary
results, any uncontrolled confounder would need to be
associated with both alcohol consumption and risk of AF and
generally be unrelated to the other covariates in our multivari-
able models.
Although we relied on self-reported alcohol consumption
in this study, the measures used to estimate alcohol consump-
tion have been found to be valid when compared with a
formal dietary interview in Danish populations.32 Further-
more, we found a correlation of alcohol use and HDL
cholesterol of the expected magnitude.33
We relied on a hospital registry and periodic study-related
ECGs to document cases of AF. Because study examinations
occurred every 5 to 10 years, it is likely that we missed some
cases of AF among participants who were not hospitalized
during the follow-up period.
Although the CCHS is a population-based cohort study
with a high participation rate, participants are nearly all
white, native-born Danish adults. As a result, our results must
be generalized to other populations with an appropriate
degree of caution.
Although we found that risk of AF appeared to be higher
only among consumers of 35 drinks per week, it is difficult to
determine the exact nature of the dose-response relationship,
especially at high levels of intake that were relatively uncom-
mon, although we explored this with spline analyses that
provided similar findings. This was especially true for anal-
yses of individual beverage types, because consumption of
any individual beverage was limited in many cases. We also
lack power to exclude a modest increase in risk associated
with moderate drinking, although our data suggest that there
is not a substantially increased risk associated with moderate
intake.
In summary, alcohol consumption of 35 or more drinks per
week was associated with an increased risk of AF among men
in a population-based cohort of more than 16 000 adults. This
finding supports the widely held, but rarely examined, clini-
cal observation that heavy alcohol use can lead to AF and
confirms the cardiotoxic effects of heavy drinking. Studies on
the effects of alcohol use on patients with established AF are
still needed.
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